The METAOD006 (OPTIONS) oral Phase 2b trial measured weight at 12 and 24 weeks
Neural Pathways and Weight Loss: Semaglutide modulates food preference, reduces food intake, and causes weight loss without decreasing energy expenditure by interacting with the brain through several pathways involved in food intake and energy expenditure (Gabery et al., 2020)
doi: 10.1186/s12933-021-01366-8 88 LeeMMYKristensenSLGersteinHCMcMurrayJJVSattarN
Mounjaro, or tirzepatide, activates two related hormone pathways: GLP-1 and GIP
Initial small trials from 2016 to 2017, including EXSCEL, FIGHT, and LIVE, were not supportive of the use of GLP-1RAs in HFrEF with negative outcomes related to cardiovascular events [53,54,55]
While ibuprofen and semaglutide do not have a direct pharmacological interaction, their combined effects on your digestive system and kidney function require careful consideration